Contact
Privacy
DMCA
Robuta
https://stanfordhealthcare.org/publications/763/763005.html
763005 | Stanford Health Care
Onasemnogene abeparvovec gene-replacement therapy (GRT) for spinal muscular atrophy Type 1 (SMA1): Pivotal phase 3 study (STR1VE) update
stanford
health
care